ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,758Medicare Part D Prescriptions Filled, Including Refills

Rank: 12 out of 96

$912K Total Retail Price of All Prescriptions

Rank: 11 out of 96

400 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
65% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

16% of this provider’s 400 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

12% of this provider’s 400 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Risky Drugs to Seniors

1% of this provider’s 12,804 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

33% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$66 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

34 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
AMLODIPINE BESYLATE 715 678 1 2
FUROSEMIDE 608 595 2 4
SIMVASTATIN 480 434 3 1
ATORVASTATIN CALCIUM 341 319 4 12
WARFARIN SODIUM 334 334 5 6
METOPROLOL TARTRATE 317 297 6 7
LEVOTHYROXINE SODIUM 303 275 7 3
OMEPRAZOLE 264 249 8 5
DONEPEZIL HCL 263 263 9 8
MIRTAZAPINE 246 246 10 14
NAMENDA 235 223 11 11
DIOVAN 234 229 12 17
METFORMIN HCL 199 189 13 13
HYDROCODONE-ACETAMINOPHEN 187 140 S3 14 52
LACTULOSE 179 159 15 37
ALBUTEROL SULFATE 163 163 16 83
HYDROCHLOROTHIAZIDE 161 141 17 16
LOSARTAN POTASSIUM 159 156 18 23
ZOLPIDEM TARTRATE 151 149 19 18
EXELON 150 140 20 47
POTASSIUM CHLORIDE 140 140 21 19
CARVEDILOL 131 128 22 22
SERTRALINE HCL 128 119 23 15
DOXAZOSIN MESYLATE 125 125 24 132
LISINOPRIL 123 109 25 10
JANUVIA 122 120 26 49
ESCITALOPRAM OXALATE 117 117 27 24
QUETIAPINE FUMARATE 117 106 27 32
ADVAIR DISKUS 112 99 29 46
OXYCODONE-ACETAMINOPHEN 112 110 S2 29 26
ATENOLOL 109 102 31 30
DIVALPROEX SODIUM 105 93 32 41
TAMSULOSIN HCL 104 101 33 29
METOPROLOL SUCCINATE 104 104 33 9
PANTOPRAZOLE SODIUM 97 83 35 44
CLOPIDOGREL 91 91 36 27
LEVOFLOXACIN 90 84 37 59
ENALAPRIL MALEATE 89 89 38 28
DIGOXIN 89 89 38 34
FAMOTIDINE 85 80 40 21
PROCRIT 85 85 40 210
LEVETIRACETAM 84 71 42 61
CRESTOR 82 70 43 39
XARELTO 80 74 44 218
SPIRIVA 80 66 44 67
AMOX TR-POTASSIUM CLAVULANATE 79 73 46 135
ALENDRONATE SODIUM 79 79 46 36
LATANOPROST 78 78 48 77
AZITHROMYCIN 74 65 49 54
PREDNISONE 72 66 50 58
PROAIR HFA 71 56 51 72
POLYETHYLENE GLYCOL 3350 70 63 52 53
PLAVIX 68 67 53 42
LIPITOR 66 62 54 63
NOVOLOG 64 64 55 142
GABAPENTIN 60 59 56 20
OXYCODONE HCL 60 17 S2 56 95
VESICARE 60 60 56 121
LEVEMIR 59 59 59 247
FINASTERIDE 59 59 59 85
HUMALOG 59 45 59 120
LIDODERM 58 58 62 45
SANTYL 56 56 63 71
NEXIUM 54 53 64 40
RESTASIS 54 54 64 258
SULFAMETHOXAZOLE-TRIMETHOPRIM 54 51 64 127
ISOSORBIDE MONONITRATE ER 50 50 67 60
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 18, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.